Keywords: devco, pharmaceuticals, completes, ph, ii, parkinson, drug

DevCo Pharmaceuticals completes Ph II with Parkinson's drug

Article | 29 November 1999

Print This

DevCo Pharmaceuticals of the UK has completed a Phase II study of itsanti-Parkinson's drug BTS 74 398, originally discovered and developed by ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in